The global contraceptive drugs and devices market is anticipated to grow at a CAGR of 6.5% during forecast period. The strong growth is primarily attributed to rising awareness regarding reproductive health and government initiatives to deal with the exponentially rising population across the globe. The correct selection of contraceptive drugs and devices plays a vital role in prevention against unwanted pregnancy and sexually transmitted diseases.
The use of pills, condoms, long acting reversible contraceptives (LARC) and female sterilization are the most common type of contraceptive methods adopted by couple across the globe. Based on data published by Centers for Disease Control and Prevention, approximately 65% of women aged 15–49 used some type of contraceptive method during 2015 – 2017.
The rest 35% of women not using any contraceptive methods was due to limited availability and lack of awareness in African and Asian countries. This is anticipated to offer prominent opportunities to contraceptive drug and device manufacturers to expand business operations in Asia and Africa.
Moreover, rising prevalence of sexually transmitted diseases is anticipated to be another factor fueling the adoption of contraceptive drugs and devices market during forecast period. North America dominated the global contraceptive drugs and devices market owing to high penetration of contraceptive drugs and devices across the region.
Additionally, fueled by government initiatives to uplift awareness regarding the use of contraceptive drugs and devices is anticipated to be most important parameter shaping the North America contraceptive drugs and devices market. Asia Pacific is anticipated to be the fastest growing market during forecast period owing to government initiative to promote reproductive safety and rising consumer awareness regarding the use of different contraceptive drugs and devices.
Major players dominating the global contraceptive drugs and devices market include Agile Therapeutics, ANI Pharmaceuticals, Inc., Bayer AG, Church & Dwight Co., Inc., Mayer Laboratories, Inc., Merck & Co., Inc., Pantarhei Bioscience, Pfizer Inc., Reckitt Benckiser Group plc, and Teva Pharmaceutical Industries Ltd.
The report titled “Contraceptive Drugs and Devices Market - Global Market Share, Trends, Analysis and Forecasts, 2023-2032”, wherein 2021 is historic period, 2022 is the base year, and 2023 to 2032 is forecast period. Additionally, the study takes into consideration the competitive landscape, wherein the report would provide company overview and market outlook for leading players in the global contraceptive drugs and devices market.
Furthermore, the report would reflect on the key developments, global & regional sales network, business strategies, security & exchange overview, research & development activities, production facilities, product portfolio, employee strength, and key executive, for all the players considered under the scope of study. For instance, Bayer Group reported revenues of US$ 44,303.1 Billion in 2018 and the segment and geographic analysis of the company indicates Pharmaceuticals business segment of the company dominated revenue in 2018 with Europe, Middle East, & Africa (EMEA), and North America being the largest revenue generating geographies.
The global contraceptive drugs and devices market is segmented based on product type, and geography. Based on product type the global market is segmented into contraceptive drugs, and contraceptive devices. The contraceptive drugs are further sub-segmented into oral contraceptive pills, contraceptive injectable, and topical contraceptives. Similarly, the contraceptive devices are further sub-segmented into female contraceptive devices, and male contraceptive devices or male condoms. The female contraceptive devices are further sub-segmented into female condoms, diaphragms, sponges, Intra-Uterine Devices (IUD) (hormonal IUD, and copper IUD), sub-dermal contraceptive implants, and vaginal rings. Based on geography, the global contraceptive drugs and devices market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America. Additionally, the study provides in-depth analysis of prominent players holding majority share of the market with a focus on all operating business segment, and would identify the segment of the company focusing on contraceptive drugs and devices.
Further, market share of company in the global contraceptive drugs and devices market would also be calculated. For instance, Bayer Group operates through four business segments namely Pharmaceuticals, Consumer Health, Crop Science, and the Animal Health business unit. Contraceptive drugs and devices are delivered under Pharmaceuticals business segment of the company with largest revenue contribution in 2018.
The study takes into consideration the key competitive information such as business strategy, product portfolio, key development, SWOT analysis, and research and development focus of all the contraceptive drugs and devices companies. Furthermore, the global contraceptive drugs and devices market study would take into consideration the participants engaged throughout the supply chain and value chain of the market, along with their contribution.
Product portfolio would focus on all the products under the contraceptive drugs and devices market business segment of the company. Similarly, the recent development section would focus on the latest developments of company such as strategic alliances and partnerships, merger and acquisition, new product launched and geographic expansion in the global Contraceptive Drugs and Devices market arena.
Key players in the global contraceptive drugs and devices market are strongly focusing on developing improved contraceptive drugs and devices to remain competitive in global market.
Market Segmentation:
By product type
By Geography
Based on contraceptive drugs, the contraceptive drugs and devices market is segmented into oral contraceptive pills, contraceptive injectable, and topical contraceptives.
The global contraceptive drugs and devices market segmented on the basis of product type, and geography.
The base year is 2021 in contraceptive drugs and devices market.
Copyright © 2024 Same Page Management Consulting Pvt. Ltd. (insightSLICE) | All Rights Reserved